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ABNORMAL CELL PROLIFERATION IN PSORIASIS*
GERALD D. WEINSTEIN, M.D. AND PHILLIP FROST, M.D.
Psoriasis has been described as a disease of skin. It has been established that in a population
epidermal hyperplasia which is manifested of cells exposed to the labeled DNA precursor,thymidine-3H, those cells in the DNA synthesis
clinically by excessive production of scale (1). (S) phase will incorporate the compound into the
Several reports have demonstrated that the DNA being synthesized (Fig. 1). The period of
thickened epidermis in psoriasis replaces itself availability of thymidine-3H to cells is brief, in
6 to 7 times more rapidly than the thinner epi- the order of several minutes, thereby providing apulse label for those cells in the S phase. For andermis of normal skin (1—3). The much larger interval following injection only unlabeled cells
number of germinative cells and mitoses in in mitosis are seen, which are those cells that were
psoriatic skin compared to normal has been either already in mitosis or in the G2 (post DNA
considered to be the basis for the more rapid synthesis) period at the time of injection and did
epidermal replacement (1). The present study not incorporate any thymidine-3H. Subsequently,labeled mitoses are seen, which represent the
was undertaken to determine whether the cell progression of the first cells completing DNA
cycle of individual germinative cells is faster in synthesis that incorporated thymidine-H to
psoriatic epidermis than normal and if such an reach the mitotic phase. The percent of labeled
acceleration is a significant factor in the patho- mitoses plotted against time after injection rises
and then decreases as the original population of 8
physiology of psoriasis (4). The duration of the phase cells exposed to thymidine-H has com-
phases in the cell cycle of psoriatic and normal pletely moved through the mitotic period (Fig. 2).
epidermis was determined with autoradiographic Unlabeled mitoses at this time are those cells
technics utilizing tritiated thymidine incorpora- that were in the G1 phase when thymidine-3H was
tion into skin, in vice, injected. The 8 phase is determined as the interval(in hours) between the 37% points on the ascend-
ing and descending limbs of the labeled mitoses
MATERIALS AND METHODS curve (8). The median G2 period is that interval
Patients over 40 years of age with lesions of from the time of thymidine-H injection until the
psoriasis were selected. In each patient, 0.1 ml appearance of a significant number of labeled
(5 pc) of thymidine-5H (sp act = 1.9 C/mM) was mitoses (defined as the 37% point on the ascendinginjected intradermally into each of 8 or more limb).
marked sites within psoriatic plaques. Serial The duration of the germinative cell cycle
biopsy specimens were taken from these sites at (from initosis to mitosis) was obtained by:
intervals within 24 hours and prepared histolog-
ically for autoradiography (2). Injection schedules N = Ng.,, (1)
were arranged to permit all biopsies to be taken 2', T5.,.
between 9:00 AM and 9:00 PM. The absence of
diurnal variations of labeling indices in human N, = number of cells in S phase
epidermis has been demonstrated (5). The slides T, = duration of 8 phase
were coated with Kodak NTB-3 liquid photo- N5.. = total number of germinative cells
graphic emulsion, exposed for 1—4 weeks, de- T5.. = duration of entire germinative cell
veloped and stained. With this technic, black cycle
silver grains from tritium emissions appear over N,/N5.,,. labeling index
the nuclei of cells that were synthesizing DNA at
the time of tritiated thymidine injection. '1', was previously determined from the labeled
The use of thymidine-3H as a DNA label for mitoses curve. N, is the number of labeled cells
autoradiographic analysis of cell proliferation found 30—60 minutes after thymidine-H injection.
kinetics has been reviewed in several publications The critical and difficult determination is the
(6, 7). The principles involved are briefly described number of germinative cells (N5.,.) in the epi-
here as they are applied to the study of human dermis. The germinative cells of the normal human
epidermis are considered to be only those in the
* From the Department of Dermatology, basal layer and are, therefore, easily counted, but
University of Miami School of Medicine, Miami, in psoriasis the germinative cell population con-Florida.
Accepted for publication October 6, 1967. stitutes at least the three lowermost rows ofThis investigation was supported by research epidermal cells (1, 2, 9). Individual germinative
grants from the National Institutes of Health cells are difficult to identify by routine histological(CA-10292) and the Hartford Foundation. The stains. However, the germinative population can
authors were Post-Doctoral Fellows of the N.I.H. be estimated as that population of cells in the
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lower part of the epidermis containing mitotic
figures and thymidineiH labeled cells in specimens
taken immediately after injection. The germina-
tive population can also often be delineated be-
cause these cells are relatively darker staining by
virtue of an increased nuclear/cytoplasmic ratio
compnred to the spinous (differentiated) cells
which have a greater proportion of cytoplasm per
cell. In this stndy, autorndiographs of one hour
specimens were photographed at low power and
the germinative cells in the photographs were
counted (N0.8.) and expressed as the percent of
germinative cells in S phase at any time (labeling
index). Multiple fields in specimens from 7 patients
were examined. In a similar manner the labeling
index for normal epidermis was determined by
counting the number of labeled cells in the single
germinative basal cell layer. Uninvolved, normal-
appearing skin of lower back was studied in 19
subjects including volunteers without cutaneous
disease, patients with unrelated skin diseases and
patients with psoriasis.
Since the histologic sections were cut 6 microns
thick and tritium has only a 1.5—2.0 micron range
of beta emission, a correction factor of 1.4 must
be used to compensate for those nuclei that can be
seen but yet are too far below the photographic
film for their emissions to reach the emulsion and
produce grains (10). The same technical factor
accounts for the failure of the labeled mitoses
curve to reach 100%. False-negative "unlabeled"
mitoses are recorded because they are more than
2 microns below the emulsion (11).
The duration of mitosis in the psoriatic epider-
mis was determined by counting the number of
mitotic cells and labeled cells in the germinative
population of specimens taken one hour after
thymidine-3H injection. Tm is calculated by the
following equation:
N, Nm
T,
—
Tm
Nm = number of cells in mitosis
Tm = duration of mitotic period
RESULTS
The duration of the DNA synthesis period in
psoriatic plaques was obtained from a composite
curve of the mean percentage of mitoses labeled
at each hour tested in eight patients (Fig. 2).
The number of mitoses examined at each interval
ranged from 31 to 302 with an average of 113.
The vertical bars delineate 80% confidence
limits. The S phase, representing the distance
between the 37% points, is 8.5 hours (T8). The
median G period from the curve is 4 hours. The
labeling index for psoriatie plaques in seven
patients was 22.7 2.4% (corrected) (Table I).
Using equation 1, the duration of the germinative
Cells that
differentiate
FIG. 1. The cell cycle is divided into four
phases, the length of each being constant for a
specified population of cells. Following mitosis a
certain time is spent in interphase (G) during
which the cell is involved in various metabolic
activities. It then enters the DNA synthesis period(8) during which it doubles its complement of
DNA in preparation for mitosis. A short post-
DNA synthesis period (Gi) prior to mitosis follows,
the function of which is poorly understood. Of the
two daughter cells from mitosis, on the average,
one will remain in the germinative cycle to divide
again while the other cell will differentiate by
moving outward through the epidermis.
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Fia. 2. Labeled mitoses curve to determine the
durations of the DNA synthesis and G2 pre-mitotie
periods. The curve is drawn through points each
of which represents the mean of the percent
labeled mitoses in 8 patients. An average of 113
mitoses was counted at each interval for each pa-
tient. The vertical lines represent 80% confidence
limits of each mean.
cell cycle in psoriasis was calculated to be 37.5
hours. In normal epidermis, the labeling index
was 5.2 1.5%, which is similar to a previously
reported value (9). Using the T, determined in
psoriasis of 8.5 hours (a final value for the T,
in normal epidermis is not yet completed), the
normal T9,. was tentatively calculated as 163
hours. No significant difference was found in the
labeling index between epidermis from normal
(2) 3 6 9 12 15 lB 21 24 27
Time ii Hoiri After Injection
of Tritioted Thymidine
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volunteers and the "apparently" normal epi-
dermis from psoriatic patients. Multiple micro-
scopic fields were examined in five psoriatic
patients to obtain Nm and N5 (Table II). The
duration of mitosis was calculated to be 0.26
hours. Finally, the Gj period can be determined
by subtraction in the following equation:
Tg, T5.5. — (T5 + Tg5 + Tm)
TABLE I
Labeling index in psoriatic epidermis
Patient (N5)Labeled
cells
(N55.)
Germinative
cells
N,/Ng.e.
Labeling Index
A
B
C
D
E
F
G
188
160
91
158
164
49
354
887
789
335
640
812
225
1410
21.2
20.3
25.6
24.7
20.2
21.8
25.0
Average 22.7%
S.D. 2.4
TABLE II
Ratio of mitoses to DNA synthesizing cells
in psoriatic epidermis
Patient (Nm) Mitoticcells (N5 Labeledcells % N,51N.
A
D
F
G
H
35
20
15
14
28
636
476
818
1155
1071
5.5
4.2
1.8
1.2
2.6
T9, is, thus, approximately 25 hours for the
psoriatic germinative cell.
Preliminary data for normal epidermis are
presented in Table III.
DISCUSSION
The study of cell proliferation kinetics has
(3) made great advances since the availability of
tritiated thymidine as an experimental tool in
combination with high-resolution autoradiogra-
phy. Identification and measurement of the
proliferative cell cycle and its component parts
(ill, G, S, 02) in various cell populations have
provided insight into the behavior of normal,
hyperplastic, and tumor cells. Cell cycle durations
vary from several hours to several months in
different animal species and cell types. However,
certain components of the cell cycle have rela-
tively consistent values. The 02 period is short,
ranging from 0.5—1.5 hours with exceptions to 9
hours; the DNA synthesis period (8) is about 8
hours, with a range of 4.5—30 hours. The greatest
variability is of the G1 period and accounts for
the wide ranges in cell cycles (6). Pertinent to the
present report are the results of cell proliferation
studies performed on other epithelial tissues
listed in Table IV. It is apparent that the dura-
tion of the cell cycle is in part dependent on the
animal species, type and location of epithelium,
age, hormonal and other influences.
The major difference in the duration of the
cell cycle between normal and psoriatic epidermal
cells is in the length of the G1 phase, while the
remaining parts of the cycle have proportionately
smaller, but equally significant, differences. It is
assumed that all cells within a germinative cell
population will have the same T5.5. but it is
recognized that variations occur (21). The dura-
Summary of the values for the germinative cell cycle and its component parts in psoriatic and
normal human epidermis
The median G2 period technically includes )4 of the mitotic period.
LI. (%) S (hr) Ge (hr) M (hr) Ge (hr) G.C.C. (hr)
Psoriasis 22.7 8.5 4 0.3 25 37.5
Normal 5.2 >8.5* 6_8* 1* >146* >163*
* Preliminary data.
LI. = Labeling index.
G.C.C. = Germinative cell cycle.
Average 3.1%
S.D. 1.7
TABLE III
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TABLE IV
Duration of cell cycle (Tg.e.) and DNA synthesis period (T,) in various epithelial tissues, in vivo
Epithelial Tissue Animal T5,. (hrs.) F, (hrs.) Ref.
Epidermis Mouse 150 8 12
Ear epidermis Mouse 24 days 30 13
Corneal Mouse 70 8 14
Esophagus Mouse 108 7 15
Forestomach Mouse 260 135 16
Ileum Mouse 18.7 7.5 11
Uterine Mouse 42 8.5 14
Epidermis Hairless mouse 110 5.3 10
Lens Hat 52—300 10.5 17
Vaginal Rat 13—15 6 18
Cheek pouch Hamster 142 10.2 19
Epidermis Human 152 — 9
GA. Tract Human 24 (minimum) 10—15 20
tion of the average cell cycle should reflect the
turnover time of the entire germinative cell
population.
Because of the difficulty in positively identi-
fying the germinative cell population, the labeling
index (N3/N5..) may be subject to a small
degree of error. In psoriasis, an error in the label-
ing index could be made by mistakingly including
neighboring differentiated cells as part of the
germinative cell population resulting in spuriously
low values. If corrected by deducting the differ-
entiated cells from the counts it would decrease
the T5, of psoriasis and thus further increase
the difference between the T5., of normal and
psoriatic cells.
Clinically, psoriasis can appear in different
stages of activity, with varying degrees of scaling,
erythema, and extent of involvement. Whereas
the patients chosen for this study had chronic
"steady-state" plaques, it was surprising to find
that the labeling indices were so similar (Table
I). In two additional patients with active gen-
eralized exfoliative psoriasis, labeling indices
were 27.3% and 30.8% representing an even
faster epidermal turnover time, as suggested by
the extremely rapid scale production. Therefore,
it appears that two clinically recognizable states
of psoriasis can be characterized by their cell
cycles.
Little is known about cell proliferation kinetics
in human tissues because of the limitations in
using thymidine-3H in the large doses required
for systemic intravenous administration. The
potential problems of using large doses are
obviated in this study by using small intradermal
injections, permitting an analysis of epidermal
cell kinetics in human skin in vivo. In other studies
of human cell kinetics performed with the in
vivo use of thymidine-3H, the gastrointestinal
tract has an S phase of 10—15 hours and a germi-
native cell cycle as rapid as 1 day in some epi-
thelial cells (20). In erythropoietic and granulo-
poietic cells the S phase is reported to be in the
range of 13—14 hours (22) and the average genera-
tion time of normal neutrophil precursors is about
48 hours (23). Comparable values for human
leukemic cell precursors indicate that their
generation times are about equal to that of
normal cell precursors but not shorter (24).
The mitotic index has been used in many
studies as an indicator of cell proliferation but
caution must be used in interpreting such data
because of the variations possible in mitotic
duration (25). Van Scott has demonstrated that
there is approximately a three-fold increase in
the number of mitoses in the germinative popula-
tion of psoriatic epidermis compared to normal
(1). The present study reveals that the mitotic
duration in psoriatic and normal epidermis is
about 16 minutes and 1 hour, respectively. The
same reservation would hold for a study based
on a thymidine-311 labeling index unless the T,
was experimentally determined, as in this report.
Epidermal hyperplasia has been chemically
induced in experimental animal tumor systems
and studied for alterations in cell proliferation
kinetics. The results of studies in hamster cheek
pouch epidermis and albino mouse epidermis
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indicate that a hyperplastic or malignant change
in these epithelial cells is associated with an
acceleration of the germinative cell cycle. In the
hamster cheek pouch epidermis the normal and
hyperplastic epidermal cell cycle is 142 and 42
hours respectively (19). In albino mouse epi-
dermis the is 150 and 56 hours respectively
(12). It is apparent that the hyperplastic cell
population in psoriasis has a pattern of cell
proliferation kinetics similar to that found in the
epithelium of these animals and thus psoriasis
provides an accessible model system for studying
rapid cell proliferation in humans.
The kinetics of epidermal cell proliferation in
psoriasis determined in this study support and
further extend the concept of cellular hyperplasia
as a significant factor in this disease. Not only is
the germinative cell population in psoriasis
enlarged but the germinative cycle of the indi-
vidual cell is about one fourth as long as the
normal epidermal cell.
These data provide absolute values for the
duration of the cell cycle and its component
parts in the "involved" psoriatic epidermal cell.
The faster cell turnover time may be a primary
factor in the pathophysiology of psoriasis or a
secondary effect of another as yet unidentified
abnormality. Clinically, lesions of psoriasis are
very sensitive to systemic therapy with metho-
trexate, a drug which is effective in hindering
the reproduction of proliferating cells (26).
Knowledge of the cell proliferation kinetics
should be useful in the future management of
psoriasis with cancer chemotherapeutic drugs
that are designed to specifically affect certain
parts of the cell cycle (27).
SUMMARY
Although psoriasis is characterized by a rapidly
proliferating epidermis, the reproduction rate
of the individual cell has never been ascertained.
In this study the duration of the component parts
of the germinative cell cycle was determined.
Tritiated thymidine was injected into multiple
locations of psoriatic lesions in vivo, and auto-
radiographs of sequential biopsy specimens were
analyzed.
From a graph in which the percentage of
mitoses labeled was plotted against time after
injection in 8 patients, the average DNA synthe-
sis period was calculated to be 8.5 hours. The
mean G2 period was 4 hours, and the mitotic
period was 0.26 hour. The labeling index, i.e.,
the percentage of germinative cells labeled 1
hour after injection of tritiated thymidine was
22.7 2.4% in psoriasis compared to 5.2 1.5%
in normal epidermis. It could then be calculated
that the average germinative psoriatic cell re-
produces every 37.5 hours.
These results indicate that in addition to the
presence of an increased germinative cell popula-
tion in psoriasis, the individual germinative cell
behaves abnormally, at least with regard to its
rate of proliferation.
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